Literature DB >> 15456475

Recombinant factor VIIa: a general hemostatic agent? Yes.

H R Roberts1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15456475     DOI： 10.1111/j.1538-7836.2004.00909.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

Review 1.  The role of tissue factor and factor VIIa in hemostasis.

Authors:  Nigel Mackman
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

Review 2.  Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.

Authors:  Anthony E Pusateri; Myung S Park
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

Review 3.  Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.

Authors:  R Michael Grounds; Charles Bolan
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

4.  Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant.

Authors:  Manish J Gandhi; Richard A Pierce; Lini Zhang; Marc R Moon; George J Despotis; Nader Moazami
Journal:  J Cardiothorac Surg       Date:  2007-07-06       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.